GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Cash Flow from Investing

Mega Lifesciences PCL (BKK:MEGA-R) Cash Flow from Investing : ฿-245 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2025, Mega Lifesciences PCL spent ฿270 Mil on purchasing property, plant, equipment. It gained ฿0 Mil from selling property, plant, and equipment. It spent ฿0 Mil on purchasing business. It gained ฿0 Mil from selling business. It spent ฿0 Mil on purchasing investments. It gained ฿0 Mil from selling investments. It paid ฿1Mil for net Intangibles purchase and sale. And it received ฿14 Mil from other investing activities. In all, Mega Lifesciences PCL spent ฿256 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2025.


Mega Lifesciences PCL Cash Flow from Investing Historical Data

The historical data trend for Mega Lifesciences PCL's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Cash Flow from Investing Chart

Mega Lifesciences PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -650.28 -264.68 -280.83 -250.01 1.45

Mega Lifesciences PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.42 304.60 98.88 -391.61 -256.43

Mega Lifesciences PCL Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Mega Lifesciences PCL's Cash Flow from Investing for the fiscal year that ended in Dec. 2024 is calculated as:

Mega Lifesciences PCL's Cash Flow from Investing for the quarter that ended in Mar. 2025 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-245 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mega Lifesciences PCL  (BKK:MEGA-R) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Mega Lifesciences PCL's purchase of property, plant, equipment for the three months ended in Mar. 2025 was ฿-270 Mil. It means Mega Lifesciences PCL spent ฿270 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Mega Lifesciences PCL's sale of property, plant, equipment for the three months ended in Mar. 2025 was ฿0 Mil. It means Mega Lifesciences PCL gained ฿0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Mega Lifesciences PCL's purchase of business for the three months ended in Mar. 2025 was ฿0 Mil. It means Mega Lifesciences PCL spent ฿0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Mega Lifesciences PCL's sale of business for the three months ended in Mar. 2025 was ฿0 Mil. It means Mega Lifesciences PCL gained ฿0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Mega Lifesciences PCL's purchase of investment for the three months ended in Mar. 2025 was ฿0 Mil. It means Mega Lifesciences PCL spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Mega Lifesciences PCL's sale of investment for the three months ended in Mar. 2025 was ฿0 Mil. It means Mega Lifesciences PCL gained ฿0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Mega Lifesciences PCL's net Intangibles purchase and sale for the three months ended in Mar. 2025 was ฿-1 Mil. It means Mega Lifesciences PCL paid ฿1 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Mega Lifesciences PCL's cash from discontinued investing activities for the three months ended in Mar. 2025 was 0 Mil. It means Mega Lifesciences PCL paid ฿0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Mega Lifesciences PCL's cash from other investing activities for the three months ended in Mar. 2025 was ฿14 Mil. It means Mega Lifesciences PCL received ฿14 Mil from other investing activities.


Mega Lifesciences PCL Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines